We have located links that may give you full text access.
Design and performance characteristics of the Pericarbon Stentless valve.
Journal of Heart Valve Disease 1995 July
The Pericarbon Stentless valve (PS) in an unstented bioprosthesis made of glutaraldehyde tanned bovine pericardium. Its design concept and chemical fixation process are based on those developed for the stented Pericarbon valve, which has been in clinical use for eight years. The two-sheet design and the special suture pattern with which the two pieces of pericardium are attached aim at avoiding stress concentration during function. The resulting cylindrical structure is a relatively low-profile valve conduit, which can be further trimmed by the implanting surgeon to the individual patient's specific anatomical requirements. The main advantage of the stentless concept is optimum hemodynamic characteristics, inherent in the high external/internal diameter ratio. The unique design and material selection of the PS valve offer the following advantages: Free-hand insertion similar to that with homograft aortic valves. Absence of any fabric cover or reinforcement providing a maximum effective orifice area and reduced risk of infection. Wide range of available sizes from 15 mm to 29 mm. Special methods have been developed for laboratory testing of the PS. These, and the in vitro results are presented in detail, with particular emphasis on the hydrodynamic performances under different flow conditions. Clinical implantation of the Pericarbon Stentless valve has already been started, and early results in the aortic position show good hemodynamic function and a low rate of complications.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app